254 related articles for article (PubMed ID: 2110365)
1. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
[TBL] [Abstract][Full Text] [Related]
2. Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.
Tayama M; O'Brien JS; Kishimoto Y
J Mol Neurosci; 1992; 3(4):171-5. PubMed ID: 1389998
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
4. Determination of saposin proteins (sphingolipid activator proteins) in human tissues.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157
[TBL] [Abstract][Full Text] [Related]
5. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y
Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid hydrolase activator proteins and their precursors.
Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
[TBL] [Abstract][Full Text] [Related]
8. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
9. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
10. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
Fujibayashi S; Wenger DA
Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
[TBL] [Abstract][Full Text] [Related]
11. Saposin proteins: structure, function, and role in human lysosomal storage disorders.
O'Brien JS; Kishimoto Y
FASEB J; 1991 Mar; 5(3):301-8. PubMed ID: 2001789
[TBL] [Abstract][Full Text] [Related]
12. Saposins: structure, function, distribution, and molecular genetics.
Kishimoto Y; Hiraiwa M; O'Brien JS
J Lipid Res; 1992 Sep; 33(9):1255-67. PubMed ID: 1402395
[TBL] [Abstract][Full Text] [Related]
13. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
14. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.
Harzer K; Paton BC; Christomanou H; Chatelut M; Levade T; Hiraiwa M; O'Brien JS
FEBS Lett; 1997 Nov; 417(3):270-4. PubMed ID: 9409731
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
18. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
20. Saposins (sphingolipid activator proteins) in the twitcher mutant mouse.
Shigematsu H; Morimoto S; Kishimoto Y; Weiler S; Tomich J; Barranger J; Shinohara M; Yeager AM; O'Brien JS
J Neurochem; 1990 Nov; 55(5):1659-62. PubMed ID: 2120388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
